Advice
Recommended for restricted use within NHS Scotland.
RECOMMENDATION.
Risperdal Quicklet, for the treatment of acute and chronic schizophrenia and other similar psychotic conditions, should be reserved for those patients in whom rapid oral absorption is indicated.
Download detailed advice21KB (PDF)
Medicine details
- Medicine name:
- Risperidone orodispersible tablets (Risperdal Quicklet®)
- SMC ID:
- 41/03
- Indication:
- Acute and chronic schizophrenic psychoses
- Pharmaceutical company
- Janssen-Cilag Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 09 May 2003